VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.98 Cr | ₹2.49 Cr | ₹2.44 Cr | ₹3.14 Cr | ₹2.82 Cr |
What is the latest Contingent Liabilities ratio of VIMTA LABS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.98 Cr |
Mar2023 | ₹2.49 Cr |
Mar2022 | ₹2.44 Cr |
Mar2021 | ₹3.14 Cr |
Mar2020 | ₹2.82 Cr |
How is Contingent Liabilities of VIMTA LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.98 Cr | 100.12 | |
Mar2023 | ₹2.49 Cr | 1.97 | |
Mar2022 | ₹2.44 Cr | -22.22 | |
Mar2021 | ₹3.14 Cr | 11.16 | |
Mar2020 | ₹2.82 Cr | - |
Compare Contingent Liabilities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,003.8 Cr | -2.9% | -12.4% | 76.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -2.9% |
-12.4% |
76.6% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses